Notice ID: a509948806dd4ec197bcfd82ad154320Combined Synopsis/Solicitation
Acquisition of cGMP-grade GS-441524 for the Treatment of COVID-19
Archived on February 8, 2022. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 9:00 AM UTC−05:00
- Posted
- February 1, 2022
- Notice type
- Combined Synopsis/Solicitation
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- 75N95022Q00102
- Notice ID
- a509948806dd4ec197bcfd82ad154320
Description
THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Avisa Pharma Solutions, Inc. (dba Cambrex), 3501 Tricenter Blvd Ste C, Durham, NC 27713-1868. To ensure consistency among material, the current requirement must be manufactured by the same vendor that is manufacturing the non-GMP material for the same project under Contract No. 75N95021P00063. Therefore, this acquisition is restricted to Avisa Pharma Solutions, Inc. (dba Cambrex). The purpose of this acquisition is to obtain 2-3Kg of cGMP GS-441524. See attachments for complete requirement details.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N95022Q00102- Combined Synopsis
- Combined SynopsisCurrentFeb 1, 2022
Acquisition of cGMP-grade GS-441524 for the Treatment of COVID-19
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N95022Q00102
Archive Date
Feb 8, 2022
Office Address
Bethesda, MD, 20892